BioWorld

March 11, 2005

View Archived Issues

Progenics' Constipation Drug Positive In Phase III Top Line

Read More

New Insights Into Neurons, Their Autism Balancing Act

Read More

Vitex, Panacos Merger Approved; $20M Placement Now Complete

Read More

Other News To Note

Read More

Vivus' Offering Raises $21M For Sexual Dysfunction Trials

Vivus Inc. is raising $21.25 million in a public offering to fund clinical trials for four product candidates in sexual dysfunction. (BioWorld Today) Read More